SMYD5 and neoplasm: To confirm the overexpression of SMYD5 in LIHC, we analyzed immunohistochemical staining and protein expression of LIHC tumor tissues and normal tissues from the Human Protein Atlas (HPA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC).